Skip to main content

Table 6 Clinical characteristics of patients with PPP (n = 33)

From: Prophylactic temporary abdominal aortic balloon occlusion for patients with pernicious placenta previa: a retrospective study

GroupA (n = 17) GroupB (n = 16) P value
Estimated blood loss (ml) 3167.65 ± 3255.71 2831.25 ± 1906.03 0.722
Tota transfusion (ml) 5497.76 ± 4251.83 5200.00 ± 2580.18 0.811
Red blood cell transfusion(u) 8.35 ± 10.01 8.00 ± 5.84 0.903
Blood plasma transfusion (ml) 811.76 ± 986.08 712.50 ± 565.54 0.727
Platelet transfusion(u) 0.41 ± 1.00 0.25 ± 0.45 0.559
Fibrinogen transfusion(g) 1.44 ± 2.84 0.94 ± 1.39 0.520
Prothrombin complex transfusion(u/100) 2.82 ± 6.29 3.38 ± 6.23 0.802
Postoperative hospital stay (day) 7.82 ± 4.75 6.75 ± 2.57 0.429
Preoperative hemoglobin(g/L) 113.76 ± 13.75 110.00 ± 21.49 0.551
Preoperative creatine (umol/L) 51.53 ± 12.74 42.69 ± 9.04 0.029#
Preoperative urea nitrogen (mmol/L) 3.43 ± 1.05 2.82 ± 0.94 0.089
Postoperative hemoglobin at 24 h(g/L) 99.41 ± 17.53 95.00 ± 13.07 0.421
Postoperative creatine at 24 h (umol/L) 59.06 ± 24.06 45.19 ± 11.20 0.044#
Postoperative urea nitrogen at 24 h (mmol/L) 3.13 ± 1.42 2.69 ± 1.03 0.315
Spinal anesthesia 8 (47.1%) 9 (56.3%) 0.732
Preoperative ureteral stent placement 12 (70.6%) 10 (62.5%) 0.721
  1. PPP pernicious placenta previa
  2. #p-value less than 0.05 was considered statistically significant